Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
42.94
-1.18 (-2.67%)
Oct 16, 2026, 4:00 PM EDT - Market closed

Ionis Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 25 analysts polled by S&P Global, Ionis Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $83.83. The average 1-year stock price forecast is 95.23% higher than the current stock price, while the lowest is $54 (+25.76%) and the highest is $105 (+144.53%).

Price Target: $83.83 (+95.23%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$54$83.83$85$105
Change+25.76%+95.23%+97.95%+144.53%

Analyst Ratings

The average analyst rating for Ionis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy121210101011
Buy989999
Hold544555
Sell000000
Strong Sell000000
Total262423242425

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Truist Financial
Truist Financial
Buy
Initiates
$46 → $88
BuyInitiates$46 → $88+104.94%Oct 14, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$100
BuyReiterates$100+132.88%Oct 9, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
$91
BuyMaintains$91+111.92%Oct 9, 2026
RBC Capital
RBC Capital
Buy
Maintains
$85
BuyMaintains$85+97.95%Oct 9, 2026
BMO Capital
BMO Capital
Hold
Maintains
$54
HoldMaintains$54+25.76%Sep 24, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
919.12M
from 943.71M
Decreased by -2.61%
Revenue Next Year
1.36B
from 919.12M
Increased by 48.18%
EPS This Year
-2.70
from -1.54
EPS Next Year
-1.11
from -2.70
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
810.46M587.37M787.65M705.14M943.71M919.12M
Revenue Growth
11.13%-27.53%34.10%-10.48%33.83%-2.61%
Operating Income
-30.19M-410.19M-353.73M-475.08M-381.68M-581.71M
Net Income
-28.60M-269.72M-366.29M-453.90M-381.39M-576.55M
EPS
-----1.54-2.70
Free Cash Flow
-----320.03M-533.00M
No. Analysts
-----24
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.2B
Avg919.1M
Low783.0M

Revenue Growth

Revenue Growth202620272028
High
24.7%
Avg
-2.6%
Low
-17.0%

EPS Forecast

EPS202620272028
High-2.12
Avg-2.70
Low-3.70

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-